Cryoport (CYRX) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

CYRX Stock Forecast


Cryoport stock forecast is as follows: an average price target of $23.25 (represents a 215.04% upside from CYRX’s last price of $7.38) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

CYRX Price Target


The average price target for Cryoport (CYRX) is $23.25 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $52.00 to $8.00. This represents a potential 215.04% upside from CYRX's last price of $7.38.

CYRX Analyst Ratings


Buy

According to 6 Wall Street analysts, Cryoport's rating consensus is 'Buy'. The analyst rating breakdown for CYRX stock is 0 'Strong Buy' (0.00%), 3 'Buy' (50.00%), 3 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Cryoport Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 07, 2024Matthew StantonJefferies$8.00$7.792.70%8.40%
Jul 31, 2024Yuan ZhiB.Riley Financial$15.00$9.0565.75%103.25%
May 03, 2024Yuan ZhiB.Riley Financial$19.00$15.9519.12%157.45%
Apr 04, 2024Matthew StantonJefferies$21.00$18.3414.50%184.55%
Mar 13, 2024David SaxonNeedham$18.00$14.3625.35%143.90%
May 06, 2022Paul KnightKeyBanc$52.00$24.17115.14%604.61%
Row per page
Go to

The latest Cryoport stock forecast, released on Aug 07, 2024 by Matthew Stanton from Jefferies, set a price target of $8.00, which represents a 2.70% increase from the stock price at the time of the forecast ($7.79), and a 8.40% increase from CYRX last price ($7.38).

Cryoport Price Target by Period


1M3M12M
# Anlaysts--5
Avg Price Target--$16.20
Last Closing Price$7.38$7.38$7.38
Upside/Downside-100.00%-100.00%119.51%

In the current month, the average price target of Cryoport stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Cryoport's last price of $7.38. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 18, 2024UBSNeutralNeutralHold
Aug 07, 2024Jefferies-HoldDowngrade
Jul 31, 2024B. RileyNeutralBuyUpgrade
May 03, 2024UBSBuyBuyHold
May 03, 2024B. Riley-NeutralDowngrade
Mar 15, 2024UBSBuyBuyHold
Jul 17, 2023KeyBanc-Sector WeightDowngrade
Jul 13, 2023NeedhamBuyBuyHold
Feb 24, 2023NeedhamBuyBuyHold
May 02, 2022SVB LeerinkOutperformOutperformHold
Row per page
Go to

Cryoport's last stock rating was published by UBS on Oct 18, 2024. The company gave CYRX a "Neutral" rating, the same as its previous rate.

Cryoport Financial Forecast


Cryoport Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$57.26M$56.16M$57.02M$62.82M$60.36M$60.46M$64.15M$52.30M$56.44M$56.69M$56.19M$53.28M$48.36M$11.17M$9.39M$9.77M$9.24M$9.58M
Avg Forecast$71.26M$69.46M$67.24M$66.17M$64.31M$62.04M$61.33M$58.88M$58.64M$58.06M$57.56M$58.78M$58.39M$55.24M$58.29M$62.15M$58.26M$69.95M$64.58M$52.27M$57.71M$54.44M$51.15M$46.78M$44.03M$10.55M$8.93M$9.72M$9.20M$9.49M
High Forecast$73.18M$71.34M$69.05M$67.96M$66.04M$63.71M$62.99M$60.72M$59.46M$58.13M$57.60M$58.85M$60.26M$55.24M$59.86M$63.83M$59.83M$69.95M$64.58M$52.27M$57.71M$54.44M$51.15M$46.78M$44.03M$10.55M$8.93M$9.72M$9.20M$9.49M
Low Forecast$69.46M$67.71M$65.54M$64.50M$62.68M$60.47M$59.78M$57.12M$57.76M$57.98M$57.52M$58.72M$57.49M$55.24M$56.82M$60.58M$56.79M$69.95M$64.58M$52.27M$57.71M$54.44M$51.15M$46.78M$44.03M$10.55M$8.93M$9.72M$9.20M$9.49M
# Analysts44443335633475632222345691599168
Surprise %------------0.98%1.02%0.98%1.01%1.04%0.86%0.99%1.00%0.98%1.04%1.10%1.14%1.10%1.06%1.05%1.01%1.01%1.01%

Cryoport's average Quarter revenue forecast for Mar 24 based on 4 analysts is $58.78M, with a low forecast of $58.72M, and a high forecast of $58.85M. CYRX's average Quarter revenue forecast represents a 2.66% increase compared to the company's last Quarter revenue of $57.26M (Dec 23).

Cryoport EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts44443335633475632222345691599168
EBITDA------------$-12.85M$-16.91M$-18.33M$-6.04M$-9.18M$-349.00K$-3.79M$-7.47M$-4.41M$-7.00K$856.00K$3.16M$-3.18M$-9.53M$-4.51M$-3.08M$374.35K$-11.43M
Avg Forecast$-28.44M$-27.72M$-26.83M$-26.41M$-25.67M$-24.76M$-24.48M$-23.50M$-23.40M$-23.17M$-22.97M$-4.90M$-23.30M$-22.05M$-23.26M$-4.45M$-9.32B$-17.84M$-16.47M$-4.05M$-14.72M$-13.88M$-13.04M$4.55M$-11.23M$-2.69M$-2.28M$-2.01M$-2.35M$-2.42M
High Forecast$-27.72M$-27.02M$-26.16M$-25.74M$-25.02M$-24.13M$-23.86M$-22.79M$-23.05M$-23.14M$-22.95M$-3.92M$-22.94M$-22.04M$-22.67M$-3.56M$-7.46B$-17.84M$-16.47M$-3.24M$-14.72M$-13.88M$-13.04M$5.46M$-11.23M$-2.69M$-2.28M$-1.61M$-2.35M$-2.42M
Low Forecast$-29.21M$-28.47M$-27.56M$-27.12M$-26.36M$-25.43M$-25.14M$-24.23M$-23.73M$-23.20M$-22.99M$-5.88M$-24.05M$-22.05M$-23.89M$-5.34M$-11.19B$-17.84M$-16.47M$-4.86M$-14.72M$-13.88M$-13.04M$3.64M$-11.23M$-2.69M$-2.28M$-2.42M$-2.35M$-2.42M
Surprise %------------0.55%0.77%0.79%1.36%0.00%0.02%0.23%1.85%0.30%0.00%-0.07%0.70%0.28%3.54%1.98%1.53%-0.16%4.72%

4 analysts predict CYRX's average Quarter EBITDA for Sep 21 to be $-13.88M, with a high of $-13.88M and a low of $-13.88M. This is -1722.00% lower than Cryoport's previous annual EBITDA (Jun 21) of $856.00K.

Cryoport Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts44443335633475632222345691599168
Net Income------------$-62.39M$-15.27M$-20.36M$-5.57M$-9.44M$-5.32M$-9.18M$-13.40M$-260.09M$-6.53M$-5.39M$-3.53M$-11.53M$-11.42M$-5.80M$-3.94M$-947.54K$-12.47M
Avg Forecast$-11.39M$-11.96M$-12.40M$-12.65M$-12.17M$-12.55M$-13.17M$-13.90M$-14.08M$-15.28M$-19.60M$-10.58M$-14.00M$-15.72M$-11.72M$-9.62M$-9.53B$-7.00M$-7.43M$-8.74M$-7.59M$-7.40M$-5.98M$-4.51M$-1.93M$-6.25M$-5.26M$-2.58M$-3.67M$-3.45M
High Forecast$-11.02M$-11.56M$-11.99M$-12.23M$-11.77M$-12.14M$-12.74M$-8.85M$-8.80M$-14.78M$-18.95M$-8.46M$-11.29M$-15.20M$-11.33M$-7.69M$-7.62B$-7.00M$-7.43M$-6.99M$-7.59M$-7.40M$-5.98M$-3.61M$-1.93M$-6.25M$-5.26M$-2.06M$-3.67M$-3.45M
Low Forecast$-11.79M$-12.38M$-12.84M$-13.09M$-12.60M$-12.99M$-13.63M$-20.22M$-19.36M$-15.82M$-20.28M$-12.69M$-17.16M$-16.27M$-12.13M$-11.54M$-11.43B$-7.00M$-7.43M$-10.49M$-7.59M$-7.40M$-5.98M$-5.41M$-1.93M$-6.25M$-5.26M$-3.09M$-3.67M$-3.45M
Surprise %------------4.46%0.97%1.74%0.58%0.00%0.76%1.24%1.53%34.28%0.88%0.90%0.78%5.99%1.83%1.10%1.53%0.26%3.61%

Cryoport's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CYRX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Cryoport SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts44443335633475632222345691599168
SG&A------------$38.81M$36.02M$38.80M$33.24M$32.63M$30.23M$30.56M$26.62M$27.59M$23.90M$24.69M$21.39M$26.25M$14.48M$9.03M$7.11M$4.74M$15.34M
Avg Forecast$45.87M$44.71M$43.28M$42.59M$41.39M$39.93M$39.47M$37.90M$37.74M$37.37M$37.05M$21.01M$37.59M$35.55M$37.52M$19.10M$37.50M$43.63M$40.28M$17.36M$35.99M$33.95M$31.90M$27.33M$27.46M$6.58M$5.57M$4.65M$5.74M$5.92M
High Forecast$47.10M$45.92M$44.44M$43.74M$42.51M$41.01M$40.54M$39.08M$38.27M$37.42M$37.08M$25.21M$38.79M$35.55M$38.53M$22.92M$38.51M$43.63M$40.28M$20.83M$35.99M$33.95M$31.90M$32.79M$27.46M$6.58M$5.57M$5.57M$5.74M$5.92M
Low Forecast$44.71M$43.58M$42.18M$41.52M$40.34M$38.92M$38.48M$36.76M$37.17M$37.32M$37.02M$16.81M$37.00M$35.55M$36.57M$15.28M$36.55M$43.63M$40.28M$13.89M$35.99M$33.95M$31.90M$21.86M$27.46M$6.58M$5.57M$3.72M$5.74M$5.92M
Surprise %------------1.03%1.01%1.03%1.74%0.87%0.69%0.76%1.53%0.77%0.70%0.77%0.78%0.96%2.20%1.62%1.53%0.83%2.59%

Cryoport's average Quarter SG&A projection for Mar 24 is $21.01M, based on 4 Wall Street analysts, with a range of $16.81M to $25.21M. The forecast indicates a -45.87% fall compared to CYRX last annual SG&A of $38.81M (Dec 23).

Cryoport EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts44443335633475632222345691599168
EPS------------$-1.27$-0.00$-0.00$-0.12$-0.19$-0.11$-0.19$-0.27$-5.42$-0.14$-0.12$-0.08$-0.28$-0.29$-0.15$-0.11$-0.03$-0.35
Avg Forecast$-0.23$-0.24$-0.25$-0.26$-0.25$-0.25$-0.27$-0.28$-0.28$-0.31$-0.40$-0.35$-0.28$-0.32$-0.24$-0.19$-0.21$-0.14$-0.15$-0.23$-0.15$-0.15$-0.12$-0.18$-0.04$-0.13$-0.11$-0.06$-0.07$-0.07
High Forecast$-0.22$-0.23$-0.24$-0.25$-0.24$-0.25$-0.26$-0.18$-0.18$-0.30$-0.38$-0.33$-0.23$-0.31$-0.23$-0.19$-0.20$-0.14$-0.15$-0.23$-0.15$-0.15$-0.12$-0.18$-0.04$-0.13$-0.11$-0.06$-0.07$-0.07
Low Forecast$-0.24$-0.25$-0.26$-0.26$-0.25$-0.26$-0.28$-0.41$-0.39$-0.32$-0.41$-0.36$-0.35$-0.33$-0.25$-0.20$-0.21$-0.14$-0.15$-0.23$-0.15$-0.15$-0.12$-0.18$-0.04$-0.13$-0.11$-0.06$-0.07$-0.07
Surprise %------------4.48%0.00%0.00%0.62%0.93%0.78%1.26%1.18%35.25%0.93%0.99%0.44%7.17%2.29%1.41%2.00%0.35%5.00%

According to undefined Wall Street analysts, Cryoport's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CYRX previous annual EPS of $NaN (undefined).

Cryoport Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
CYRXCryoport$7.38$23.25215.04%Buy
IRTCiRhythm$83.44$121.1745.22%Buy
CDNACareDx$21.55$29.7538.05%Buy
BLFSBioLife Solutions$21.65$26.0020.09%Buy
AXNXAxonics$70.98$71.000.03%Buy
NTRANatera$151.11$120.92-19.98%Buy

CYRX Forecast FAQ


Is Cryoport a good buy?

Yes, according to 6 Wall Street analysts, Cryoport (CYRX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 50.00% of CYRX's total ratings.

What is CYRX's price target?

Cryoport (CYRX) average price target is $23.25 with a range of $8 to $52, implying a 215.04% from its last price of $7.38. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Cryoport stock go up soon?

According to Wall Street analysts' prediction for CYRX stock, the company can go up by 215.04% (from the last price of $7.38 to the average price target of $23.25), up by 604.61% based on the highest stock price target, and up by 8.40% based on the lowest stock price target.

Can Cryoport stock reach $11?

CYRX's average twelve months analyst stock price target of $23.25 supports the claim that Cryoport can reach $11 in the near future.

What are Cryoport's analysts' financial forecasts?

Cryoport's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $246.56M (high $253.46M, low $240.05M), average EBITDA is $-98.399M (high $-95.802M, low $-101M), average net income is $-51.8M (high $-45.498M, low $-59.449M), average SG&A $158.69M (high $163.14M, low $154.51M), and average EPS is $-1.048 (high $-0.921, low $-1.203). CYRX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $274.14M (high $281.53M, low $267.2M), average EBITDA is $-109M (high $-107M, low $-112M), average net income is $-48.401M (high $-46.809M, low $-50.099M), average SG&A $176.45M (high $181.21M, low $171.98M), and average EPS is $-0.979 (high $-0.947, low $-1.014).

Did the CYRX's actual financial results beat the analysts' financial forecasts?

Based on Cryoport's last annual report (Dec 2023), the company's revenue was $233.26M, which missed the average analysts forecast of $234.08M by -0.35%. Apple's EBITDA was $-38.101M, missing the average prediction of $-73.066M by -47.85%. The company's net income was $-99.587M, beating the average estimation of $-51.054M by 95.06%. Apple's SG&A was $146.88M, beating the average forecast of $129.76M by 13.20%. Lastly, the company's EPS was $-2.04, beating the average prediction of $-1.031 by 97.83%. In terms of the last quarterly report (Dec 2023), Cryoport's revenue was $57.26M, missing the average analysts' forecast of $58.39M by -1.94%. The company's EBITDA was $-12.853M, missing the average prediction of $-23.305M by -44.85%. Cryoport's net income was $-62.389M, beating the average estimation of $-14.002M by 345.59%. The company's SG&A was $38.81M, beating the average forecast of $37.59M by 3.27%. Lastly, the company's EPS was $-1.27, beating the average prediction of $-0.283 by 348.24%